LAMOTRIGINE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
13668-695 -
Package NDC
13668-695-01 -
Package NDC
13668-695-30 -
Package NDC
13668-695-72 -
Application number
ANDA217100 -
SPL ID
1b3ee868-07fa-4918-a4e4-4a4730d19485 -
SPL set ID
22225cc4-028e-43ad-8e1f-dcebdc244ecb -
UNII
U3H27498KS -
RxCUI
103968 -
RxCUI
198430 -
RxCUI
252478 -
RxCUI
252479
What the source publishes
- Labeler
- Torrent Pharmaceuticals Limited
- Active ingredients
- LAMOTRIGINE
- Form
- TABLET, ORALLY DISINTEGRATING
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "LAMOTRIGINE",
"splId": "1b3ee868-07fa-4918-a4e4-4a4730d19485",
"labels": [
{
"setId": "22225cc4-028e-43ad-8e1f-dcebdc244ecb",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=22225cc4-028e-43ad-8e1f-dcebdc244ecb",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=22225cc4-028e-43ad-8e1f-dcebdc244ecb"
}
],
"routes": [
"ORAL"
],
"labeler": "Torrent Pharmaceuticals Limited",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (13668-695-01)",
"package_ndc": "13668-695-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20260108"
},
{
"sample": false,
"description": "30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (13668-695-30)",
"package_ndc": "13668-695-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20260108"
},
{
"sample": false,
"description": "30 BLISTER PACK in 1 CARTON (13668-695-72) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (13668-695-71)",
"package_ndc": "13668-695-72",
"identifierStatus": "well-formed",
"marketing_start_date": "20260108"
}
],
"productId": "13668-695_1b3ee868-07fa-4918-a4e4-4a4730d19485",
"useDomain": "unknown",
"dosageForm": "TABLET, ORALLY DISINTEGRATING",
"productNdc": "13668-695",
"deaSchedule": null,
"genericName": "LAMOTRIGINE",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "LAMOTRIGINE",
"strength": "100 mg/1"
}
],
"applicationNumber": "ANDA217100",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260108",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175753",
"N0000008486",
"N0000175751",
"N0000187061",
"N0000000191"
],
"upc": [
"0313668696301",
"0313668694307",
"0313668695304",
"0313668693300"
],
"unii": [
"U3H27498KS"
],
"rxcui": [
"103968",
"198430",
"252478",
"252479"
],
"spl_set_id": [
"22225cc4-028e-43ad-8e1f-dcebdc244ecb"
],
"pharm_class_pe": [
"Decreased Central Nervous System Disorganized Electrical Activity [PE]"
],
"pharm_class_epc": [
"Anti-epileptic Agent [EPC]",
"Mood Stabilizer [EPC]"
],
"pharm_class_moa": [
"Organic Cation Transporter 2 Inhibitors [MoA]",
"Dihydrofolate Reductase Inhibitors [MoA]"
],
"manufacturer_name": [
"Torrent Pharmaceuticals Limited"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:13668-695_1b3ee868-07fa-4918-a4e4-4a4730d19485"